Colorectal CancerSUCCEEDNCT05980182
Engaging Black Men in Colorectal Cancer Screening
A study testing mHealth Application in people with Colorectal Cancer and CRC, run by Virginia Commonwealth University at 1 site in United States.
Trial summary
To determine the unmet needs, attitudes, barriers and facilitators of African American (AA)/ Black men use of colorectal cancer screening and describe how community leaders such as barbers may act as Community Champions to educate and facilitate screening participation. Read more about this study
- Who is it for?
- Ages 45 to 74 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Colorectal Cancer, CRC, Behavior
- What is being tested?
- mHealth Application
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- 5 Aug 2023to 25 Jun 2024
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 74 years
- Men only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adult men
- Identify as Black or African American
- Work or live in Petersburg, VA or surrounding counties
- Eligible for colorectal cancer (CRC) screening at time of study enrollment
Who cannot join
- Inability to speak or read English
- Currently up-to-date with CRC screening
Trial locations and contacts
1 site in 1 country.
United States1 site
Virginia Commonwealth University
Richmond, Virginia, 23298
About this study
Official title: SUCCEED: Engaging Black Men in Colorectal Cancer Screening (CRC) Screening
To determine the unmet needs, attitudes, barriers and facilitators of African American (AA)/ Black men use of colorectal cancer screening and describe how community leaders such as barbers may act as Community Champions to educate and facilitate screening participation.
- Conditions
- Colorectal Cancer, CRC, Behavior
- Being tested
- mHealth Application
- Keywords
- Colorectal Screening behaviors
- Medical subject headings
- Colorectal Neoplasms, Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
mHealth ApplicationBehavioural
Self-directed application (app) that is downloaded to the participant's personal device. The app contains five informational videos, that provide an orientation to the content on the app, and discuss what colorectal cancer is, and the type of CRC screening tests that are available as well as a video with a personal history. There is a a National Cancer Institute (NCI) risk calculation tool, and a family history infographic. Once the videos have been viewed participants have the option to indicate if they wish to receive a call from the healthcare clinic to discuss scheduling an appointment for screening.
| Study group | Role | What they receive |
|---|---|---|
| Tailored Screen to Save (S2S) content | Experimental | Content to be delivered using a combination of short video and text-based information optimized for delivery via Quick Response (QR) codes for smartphones. Receives: Behavioral: mHealth Application |
What is being measured
The primary outcome is the main question the study is designed to answer.
Colorectal Screening Status
The number of participants that complete screening (any type)
Measured: 3 Months
Secondary outcomes (5)
Determine Feasibility of Mobile Health (mHealth) Application -Enrollment
The number of men that enroll for the intervention (application)
Measured: Week 1
Determine the Feasibility of the mHealth Application-Videos
The number of participants that view the videos
Measured: Week 1
Determine the Feasibility of the mHealth Application- Retention
The number of participants that complete Questionnaires (>65%)
Measured: Baseline (Day 1), Week 2, and Week 12
Determine the Feasibility of the mHealth Application- Clinic/ Screening Request
The number of participants that respond to the request to contact clinic/ navigation services
Measured: Week 12
Determine the Feasibility of the mHealth Application - Sharing Content
The number of participants that share content on social network
Measured: Week 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Aug 2023
- Study start5 Aug 2023
- Primary completion25 Jun 2024
- Study completion25 Jun 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Colorectal CancerStudies of the same condition, open and under way.
- More trials run by Virginia Commonwealth UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Virginia Commonwealth University
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Sponsor
- Investigators
- Maria Thomson, Ph.D., Principal investigator, Virginia Commonwealt University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05980182
- Sponsor's protocol ID
- MCC-21-18632
- Other IDs
- HM20023619, CA264067-01
- Acronym
- SUCCEED
- Status last verified
- Aug 2025
- First submitted
- 27 Jul 2023
- Last updated
- 20 Aug 2025
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Publications
Thomson MD, Shahab GH, Cooper-McGill CA, Sheppard VB, Hill SS, Preston M, Keen Ii L. Increasing Colorectal Cancer Screening Among Black Men in Virginia: Development of an mHealth Intervention. JMIR Form Res. 2024 Oct 10;8:e50028. doi: 10.2196/50028.
PubMed 39388688
Study at a glance
From the registry record, last updated by the sponsor on 20 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- SUCCEED: Engaging Black Men in Colorectal Cancer Screening (CRC) Screening
- ClinicalTrials.gov ID
- NCT05980182
- Acronym / sponsor ID
- SUCCEED / MCC-21-18632
- Conditions
- Colorectal Cancer, CRC, Behavior
- Keywords
- Colorectal Screening behaviors
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Virginia Commonwealth UniversityUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Study start
- 5 Aug 2023 (actual)
- Primary completion
- 25 Jun 2024 (actual)
- Study completion
- 25 Jun 2024 (actual)
- First posted
- 7 Aug 2023 (actual)
- Results
- Posted 20 Aug 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To determine the unmet needs, attitudes, barriers and facilitators of African American (AA)/ Black men use of colorectal cancer screening and describe how community leaders such as barbers may act as Community Champions to educate and facilitate screening participation.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Tailored Screen to Save (S2S) content | Experimental | Behavioral: mHealth ApplicationContent to be delivered using a combination of short video and text-based information optimized for delivery via Quick Response (QR) codes for smartphones. |
Who may qualify
- Ages
- 45 to 74 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Adult men
- Identify as Black or African American
- Work or live in Petersburg, VA or surrounding counties
- Eligible for colorectal cancer (CRC) screening at time of study enrollment
Key exclusion criteria (2 listed)
- Inability to speak or read English
- Currently up-to-date with CRC screening
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| mHealth ApplicationSelf-directed application (app) that is downloaded to the participant's personal device. The app contains five informational videos, that provide an orientation to the content on the app, and discuss what colorectal cancer is, and the type of CRC screening tests that are available as well as a video with a personal history. There is a a National Cancer Institute (NCI) risk calculation tool, and a family history infographic. Once the videos have been viewed participants have the option to indicate if they wish to receive a call from the healthcare clinic to discuss scheduling an appointment for screening. | Behavioural | Tailored Screen to Save (S2S) content |
Primary outcome
Colorectal Screening Status
Time frame: 3 Months
The number of participants that complete screening (any type)
5 secondary outcomes
Determine Feasibility of Mobile Health (mHealth) Application -Enrollment
Time frame: Week 1
Determine the Feasibility of the mHealth Application-Videos
Time frame: Week 1
Determine the Feasibility of the mHealth Application- Retention
Time frame: Baseline (Day 1), Week 2, and Week 12
Determine the Feasibility of the mHealth Application- Clinic/ Screening Request
Time frame: Week 12
Determine the Feasibility of the mHealth Application - Sharing Content
Time frame: Week 12
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Aug 2025.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Derived from this study: PubMed 39388688Thomson MD, Shahab GH, Cooper-McGill CA, Sheppard VB, Hill SS, Preston M, Keen Ii L. Increasing Colorectal Cancer Screening Among Black Men in Virginia: Development of an mHealth Intervention. JMIR Form Res. 2024 Oct 10;8:e50028. doi: 10.2196/50028.
- Individual participant dataSharing planned: Yes
Related trials for Colorectal Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingObservational study
Pre- and On-treatment Multi-omics Profiling of Locally Advanced Rectal Cancer
Rectal Neoplasms
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 2
Tislelizumab in People With Colorectal Cancer
Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Maria Thomson, Ph.D. principal investigator
Virginia Commonwealt University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing mHealth Application in people with Colorectal Cancer and CRC, run by Virginia Commonwealth University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 20 Aug 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Colorectal Screening Status (time frame: 3 Months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05980182, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2025.